April 03, 2019 - Healthcare investment by corporate venture capital (CVC) firms increased a robust 51 percent year-over-year in 2018, reaching $10.9 billion, according to the latest stats from CB Insights.
CVC deals in healthcare companies increased 23 percent year-over-year last year, totaling 298, CB Insights found.
Large CVC funding rounds for Massachusetts-based biotech firms Moderna Therapeutics and Relay Therapeutics and California-based Samumed drove the healthcare investment surge.
